Maryland Capital Management Abbott Laboratories Transaction History
Maryland Capital Management
- $1.2 Billion
- Q3 2022
A detailed history of Maryland Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Maryland Capital Management holds 185,019 shares of ABT stock, worth $20.8 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
185,019
Previous 189,349
2.29%
Holding current value
$20.8 Million
Previous $20.6 Million
12.98%
% of portfolio
1.49%
Previous 1.62%
Shares
22 transactions
Others Institutions Holding ABT
# of Institutions
3,137Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.38 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.09 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.45 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...